Cargando…

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND AND PURPOSE: Irritable bowel syndrome (IBS) is defined as an association of chronic abdominal pain with bowel habit abnormalities, without clear organic dysfunction. T-type calcium channels and low-grade mucosal inflammation are linked to abdominal pain; however, medical treatments for IB...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Haggar, Sahar M, Hegazy, Sahar K, Abd-Elsalam, Sherief M, Elkaeed, Eslam B, Al-Karmalawy, Ahmed A, Bahaa, Mostafa M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867223/ https://www.ncbi.nlm.nih.gov/pubmed/35221706 http://dx.doi.org/10.2147/JIR.S346608

Ejemplares similares

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial [Retraction]
Publicado: (2022)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial
por: Pourmoghaddas, Zahra, et al.
Publicado: (2014)

Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website
por: Everitt, Hazel, et al.
Publicado: (2013)

pH-Sensitive Mebeverine Microspheres for Colon Delivery
por: Dandagi, P. M., et al.
Publicado: (2009)

Ethosuximide for Essential Tremor: An Open-Label Trial
por: Gironell, Alexandre, et al.
Publicado: (2016)

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study
por: Rai, Ramesh R., et al.
Publicado: (2021)

Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)
por: Everitt, Hazel A, et al.
Publicado: (2010)

Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Ethosuximide inhibits acute histamine- and chloroquine-induced scratching behavior in mice
por: Gadotti, Vinicius M., et al.
Publicado: (2021)

Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome – IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2017)

Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model
por: Nygaard, Haakon B, et al.
Publicado: (2015)

In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors
por: Milusheva, Miglena, et al.
Publicado: (2023)

The Anticonvulsant Ethosuximide Disrupts Sensory Function to Extend C. elegans Lifespan
por: Collins, James J., et al.
Publicado: (2008)

Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl
por: El Nabarawi, Mohamed A, et al.
Publicado: (2017)

Simultaneous determination of sulpiride and mebeverine by HPLC method using fluorescence detection: application to real human plasma
por: Walash, Mohamed I, et al.
Publicado: (2012)

Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

UV-Photoconversion of Ethosuximide from a Longevity-Promoting Compound to a Potent Toxin
por: Choi, Haeri, et al.
Publicado: (2013)

Otoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing loss
por: Sang, Lu, et al.
Publicado: (2017)

Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome
por: Aly, Rasha, et al.
Publicado: (2022)

Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
por: Staubach, KH, et al.
Publicado: (1998)

Role of Pentoxifylline and Sparfloxacin in Prophylaxis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients
por: Mostafa, Tarek Mohammed, et al.
Publicado: (2014)

Prospective of Agro-Waste Husks for Biogenic Synthesis of Polymeric-Based CeO(2)/NiO Nanocomposite Sensor for Determination of Mebeverine Hydrochloride
por: Mostafa, Gamal A. E., et al.
Publicado: (2023)

Multivariate optimization of mebeverine analysis using molecularly imprinted polymer electrochemical sensor based on silver nanoparticles
por: Nezhadali, Azizollah, et al.
Publicado: (2018)

Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
por: Hanafy, Amr Shaaban, et al.
Publicado: (2020)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021)

Comparison of the Effects of Zonisamide, Ethosuximide and Pregabalin in the Chronic Constriction Injury Induced Neuropathic Pain in Rats
por: Goyal, S, et al.
Publicado: (2015)

Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression
por: Chen, Xi, et al.
Publicado: (2015)

Bijels as a Fluid Labyrinth for Drugs: The Effect of Nanoparticles on the Release Kinetics of Ethosuximide and Dimethyl Fumarate
por: Vanoli, Valeria, et al.
Publicado: (2022)

Pentoxifylline, Inflammation, and Endothelial Function in HIV-Infected Persons: A Randomized, Placebo-Controlled Trial
por: Gupta, Samir K., et al.
Publicado: (2013)

Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial
por: Azizi, Hanieh, et al.
Publicado: (2021)

Drug-Loaded Silver Nanoparticles—A Tool for Delivery of a Mebeverine Precursor in Inflammatory Bowel Diseases Treatment
por: Todorova, Mina, et al.
Publicado: (2023)

Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression
por: Chen, Xi, et al.
Publicado: (2015)

Effects of pentoxifylline on canine platelet aggregation
por: Thomason, John M., et al.
Publicado: (2021)

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Potentiometric determination of mebeverine hydrochloride antispasmodic drug based on molecular docking with different ionophores host–guest inclusion as a theoretical study
por: Abdel-Raoof, Ahmed M., et al.
Publicado: (2023)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
por: Abo-Amer, Yousry Esam-Eldin, et al.
Publicado: (2020)

Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy
por: Younis, Yehia Sadek, et al.
Publicado: (2019)

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies
por: Khalifa, Mohamed M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_81ordjvo41ibs741qeofsldamn